300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Greece
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Kenya
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
SquareOne Venture Capital, VC Fund

SquareOne Venture Capital

VC Fund

Berlin, Germany

SquareOne Venture Capital is a VC fund in Berlin focused on Software and Artificial Intelligence. SquareOne is a Berlin-based venture capital firm. Established in 2010 and funded only with management money, SquareOne has built its way up to become a leading tech investor in Berlin.SquareOne invests in European early-stage B2B Software companies, acting both as lead or co-lead investor. Their focus is on sectors where they can add the mostvalue to your business: Enterprise Software, Software as a Service, Industry 4.0, Deep-tech (Robotics, Security, IoT, AI/ML, NLP, DevTools..)Paua provides a broad range of services and the team is truly committed in being the best partner for entrepreneurs, aiming to be the bridge between new businesses and the corporate world.

Total investments:
67
Last investment:
Lead investor:
34%

Last updated:

Industries SquareOne Venture Capital invests in

SoftwareArtificial IntelligenceSaaSMachine LearningInformation Technology

Stages SquareOne Venture Capital invests in

SeedSeries ASeries BPre-SeedFunding Round

Countries SquareOne Venture Capital invests in

GermanyUnited StatesPolandSwedenItaly

Round sizes

Seed $1.4M–$7.4MSeries A $4.2M–$20MSeries B $5M–$30M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1.4M–$7.4M
Series A
$4.2M–$20M
Series B
$5M–$30M

Investment Focus

Industry

  • Software 21 (31%)
  • Artificial Intelligence 7 (10%)
  • SaaS 6 (9%)
  • Machine Learning 5 (7%)
  • Information Technology 5 (7%)
See all 101 industries →

Stage

  • Seed 26 (39%)
  • Series A 16 (24%)
  • Series B 7 (10%)
  • Pre-Seed 5 (7%)
  • Funding Round 2 (3%)
See all 9 stages →

Country

  • Germany 23 (34%)
  • United States 6 (9%)
  • Poland 2 (3%)
  • Sweden 2 (3%)
  • Italy 1 (1%)
See all 10 countries →

Team

NameTitleInvestmentsLinksEmail
Principal Total investments: 2
Find email
Christian Buchenau
Christian Buchenau Co-Founder, Managing Director & Partner
Co-Founder, Managing Director & Partner Total investments: 25
Find email
Christophe Defforey
Christophe Defforey Co-Founding Partner
Co-Founding Partner Total investments: 0
Find email
Partner Total investments: 24
Find email
Levent Altunel
Levent Altunel Investment Associate
Investment Associate Total investments: 0
Find email
See all 6 team members →

Investments

CompanyDescriptionRoundLinks
Graph Therapeutics Graph Therapeutics
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. $5M / Seed / Jun 22, 2026
Flinn Flinn
Our vision is to make high-quality health products accessible for everyone. We will achieve this by enabling creators of health products to build and operate high-quality products with 10x efficiency. We are putting our initial focus on automating compliance and regulatory tasks for medical device manufacturers. Our product offering includesAI-enabled automation of major parts of the data collection, aggregation, evaluation, and reporting for post-market surveillance activities. $20M / Series A / Feb 19, 2026
Ultralytics Ultralytics
Ultralytics is the creator of YOLO, the world’s leading open-source real-time vision AI. Trusted by millions of developers, researchers, and enterprises globally, Ultralytics delivers state-of-the-art object detection, segmentation, and tracking models that are lighter, faster, and more accurate.Our mission is to democratize access to advancedAI, offering open-source tools alongside enterprise solutions tailored for industries such as healthcare, security, manufacturing, and autonomous systems.Backed by a global community, Ultralytics combines cutting-edge research with practical deployment to make AI accessible, scalable, and impactful. $30M / Series A / Sep 17, 2025
C1 Green Chemicals C1 Green Chemicals
Circular Carbon Chemistry is a chemical production company. They offer services that include e-fuels, quantum chemistry, circular economy, CO2 recycling, catalysis, green methanol, C1 chemistry, and carbon chemistry. Seed / Mar 19, 2025
C1 Green Chemicals C1 Green Chemicals
Circular Carbon Chemistry is a chemical production company. They offer services that include e-fuels, quantum chemistry, circular economy, CO2 recycling, catalysis, green methanol, C1 chemistry, and carbon chemistry. $16.4M / Mar 19, 2025
Phase Phase
Phase is a visual and intuitive digital design tool, reworked for the new age. $13M / Venture - Series Unknown / Feb 13, 2025
PartsCloud PartsCloud
PartsCloud is the operating system of spare parts logistics. We are giving every company the means to support their customers with the spare parts they need when they need them by offering them the necessary digital tools and connecting them to a portfolio of logistics service providers. $5.2M / Seed / Feb 05, 2025
Zuriq Zuriq
Zuriq offers scalable quantum computing hardware based on trapped ions. $4.2M / Seed / Jan 23, 2025
Graph Therapeutics Graph Therapeutics
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. $3.1M / Pre-Seed / Jan 09, 2025
Flinn Flinn
Our vision is to make high-quality health products accessible for everyone. We will achieve this by enabling creators of health products to build and operate high-quality products with 10x efficiency. We are putting our initial focus on automating compliance and regulatory tasks for medical device manufacturers. Our product offering includesAI-enabled automation of major parts of the data collection, aggregation, evaluation, and reporting for post-market surveillance activities. $6.7M / Seed / Sep 30, 2024
See all 67 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Greece
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Kenya
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does SquareOne Venture Capital invest in?

SquareOne Venture Capital invests primarily in Software, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 67 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is SquareOne Venture Capital's check size?

SquareOne Venture Capital typically joins rounds of $1.4M–$7.4M at Seed, $4.2M–$20M at Series A and $5M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SquareOne Venture Capital participates in.

How do I contact SquareOne Venture Capital?

Public channels for SquareOne Venture Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at SquareOne Venture Capital?

The team at SquareOne Venture Capital includes Charlotte Baumhauer (Principal), Christian Buchenau (Co-Founder, Managing Director & Partner) and Christophe Defforey (Co-Founding Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
SquareOne Venture Capital SquareOne Venture Capital Find emails